【结 构 式】 |
【分子编号】18303 【品名】3-[(12aR)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4(2H)-yl]phenyl methyl ether; (4aS,12aR)-4a-(3-methoxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine 【CA登记号】 |
【 分 子 式 】C24H26N2O 【 分 子 量 】358.48332 【元素组成】C 80.41% H 7.31% N 7.81% O 4.46% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III). Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol.
【1】 Nagase, H.; Kawai, K.; Hayakawa, J.; Wakita, H.; Mizusuna, A.; Matsuura, H.; Tajima, C.; Takezawa, Y.; Endoh, T.; Rational drug design and synthesis of a highly selective nonpeptide delt-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octrahydropyrido[3,4-b]acridine (TAN-67). Chem Pharm Bull 1998, 46, 11, 1695. |
【2】 Fujii, H.; et al.; Rational drug design and synthesis of opioid delta-receptor selective nonpeptidic agonists - Optical resolution of (±) TAN-67 and the pharmacological effect of each enantiomer. Symp Med Chem 1999, Abst 1P-21. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18301 | (4aS,8aR)-4a-(3-methoxyphenyl)-2-methyloctahydro-6(2H)-isoquinolinone | C17H23NO2 | 详情 | 详情 | |
(II) | 18302 | 2-Aminobenzaldehyde | 529-23-7 | C7H7NO | 详情 | 详情 |
(III) | 18303 | 3-[(12aR)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4(2H)-yl]phenyl methyl ether; (4aS,12aR)-4a-(3-methoxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine | C24H26N2O | 详情 | 详情 |
Extended Information